All In Biotech

Drug Trial Radar · NCT03033277

Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI)

Last checked: Nov 19, 2026Latest source record: Jan 26, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 320 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

320

Planned (sponsor's estimate)

Start

Feb 2016

Primary completion

Apr 2017

Study completion Jul 2018

Sponsor

Lead sponsor
Chinese Academy of SciencesGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
The Third Affiliated Hospital of Guangzhou Medical University
First posted
Jan 26, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 20 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

There is a high incidence of women suffering from Primary Ovarian Insufficiency (POI). One of the most common treatments for POI is hormone replacement therapy (HRT), but HRT doesn't work well, and it has been shown to increase the risk of blood clots in the veins, ovarian cancer, and breast cancer. The ability of MSCs to differentiate into oocyte-like cells has been previously documented. Herein the purpose of this work is to evaluate the therapeutic potential of cell therapy in women suffering from POI.

Conditions

  • Primary Ovarian Insufficiency

Interventions

  • Placebo transplantationBiological

    Intraovarian injection of placebo through vagina under the guidance of ultrasonic.

  • HUC-MSCs transplantationBiological

    Intraovarian injection of HUC-MSCs through vagina under the guidance of ultrasonic.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of mature follicleTime frame: Up to 4 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Institute of Zoology, Chinese Academy of Sciences.

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.